Boston Scientific Gets CE Marking for Defibrillator

Boston Scientific received CE Marking approval for its LIVIAN cardiac resynchronization therapy defibrillator (CRT-D).

The LIVIAN CRT-D, which is available in high-energy and standard-energy models, enables clinicians to customize therapy based on a patient’s individual needs, the company said.

This is the first approval of a Boston Scientific cardiac rhythm management device to treat heart failure. The LIVIAN CRT-D is pending approval by the FDA and is not available for sale in the U.S.